 Connection
Edward Yeh to Atherosclerosis
This is a "connection" page, showing publications Edward Yeh has written about Atherosclerosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.868 |
|
|
|
-
Calabr? P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009 Jun; 31(1):79-94.
Score: 0.274
-
Yeh ET, Khan BV. The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis. J Thromb Haemost. 2006 Nov; 4(11):2308-16.
Score: 0.228
-
Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, Sullivan MA, Taunton J, Yeh ET, Fujiwara K, Abe J. Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest. 2015 Mar 02; 125(3):1299-310.
Score: 0.102
-
Heo KS, Chang E, Le NT, Cushman H, Yeh ET, Fujiwara K, Abe J. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Circ Res. 2013 Mar 15; 112(6):911-23.
Score: 0.089
-
Willerson JT, Cable G, Yeh ET. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Tex Heart Inst J. 2009; 36(6):530-9.
Score: 0.067
-
Calabr? P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol. 2005 Nov; 20(6):541-6.
Score: 0.054
-
Paul A, Yeh ET, Chan L. A proatherogenic role for C-reactive protein in vivo. Curr Opin Lipidol. 2005 Oct; 16(5):512-7.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|